BiotechTube

Zotepine + Risperidone

ApprovedTerminated
0 watching 0 views this week🔥 Hot
85
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
✓
Phase 3
5
Approved
Indication / Disease

Schizophrenia

Conditions

Schizophrenia

Trial Timeline

Mar 1, 2007 → Dec 1, 2009

NCT ID
NCT00418873

About Zotepine + Risperidone

Zotepine + Risperidone is a approved stage product being developed by Astellas Pharma for Schizophrenia. The current trial status is terminated. This product is registered under clinical trial identifier NCT00418873. Target conditions include Schizophrenia.

Hype Score Breakdown

Clinical
30
Activity
20
Company
10
Novelty
10
Community
12

Clinical Trials (1)

NCT IDPhaseStatus
NCT00418873ApprovedTerminated

Competing Products

20 competing products in Schizophrenia

See all competitors
ProductCompanyStageHype Score
antipsychotic dose increaseEli LillyPre-clinical
23
Olanzapine + PlaceboEli LillyPhase 3
77
Olanzapine + AripiprazoleEli LillyApproved
85
olanzapine therapyEli LillyApproved
85
olanzapine-RAIM + placeboEli LillyPhase 2
52
Clozapine + OlanzapineEli LillyApproved
85
AtomoxetineEli LillyApproved
85
Risperidone + Placebo + LY2140023Eli LillyPhase 2
52
Olanzapine + olanzapine + risperidoneEli LillyApproved
85
ASP4345 + Matching PlaceboAstellas PharmaPhase 1
33
ASP4345 + placebo + risperidone + quetiapine + olanzapine + ziprasidone + aripiprazole + brexpiprazole + paliperidone + lurasidoneAstellas PharmaPhase 2
52
ASP6981 + PlaceboAstellas PharmaPhase 1
33
SAPHRIS + AsenapineSun PharmaceuticalPhase 1
33
Torrent's Quetiapine Fumarate TabletsTorrent PharmaceuticalsPhase 1
33
Olanzapine HydrochlorideEli LillyPhase 1/2
41
Rapid-Acting Intramuscular Olanzapine + PlaceboEli LillyPhase 3
77
Pomaglumetad methionilEli LillyPhase 3
77
OlanzapineEli LillyApproved
85
Intramuscular Olanzapine Depot + PlaceboEli LillyPhase 3
77
olanzapine + atomoxetine + placeboEli LillyPhase 1/2
41

Other Products from Astellas Pharma

Tacrolimus, Prograf®Approved
85
micafungin + voriconazoleApproved
85
mirabegron + solifenacinApproved
85
Zolpidem (Myslee®) + placeboApproved
85
TacrolimusApproved
85